3 results
P
cirrhosis patients with OHE
I/C
albumin infusion
O
resolution of OHE, inpatient mortality, albumin-associated adverse events
P
1746
I/C
probiotics, synbiotics, fecal microbiota transplant (FMT), placebo/no treatment
O
reversed minimal HE (MHE), reduced overt HE (OHE) development, decreased ammonia levels, decreased NCT level, decreased hospitalization rates
P
patients with cirrhosis and acute upper gastrointestinal bleeding
I/C
lactulose therapy, placebo
O
lower risk of overt hepatic encephalopathy